Financial Controller

Company Summary

Acrivon Therapeutics, is a very well-funded ($100M+), fast-growing, Pre-IPO, global, clinical stage oncology company that leverages its unique precision medicine platform, called Acrivon Predictive Precision Proteomics (AP3), for development of its drug pipeline. AP3 is used to generate proprietary OncoSignature® companion diagnostics to identify the patients who will benefit from Acrivon’s medicines. The name Acrivon (derived from Greek for “accurate”) embodies how Acrivon’s  OncoSignature® tests link the patient’s active tumor-driving mechanisms with the drug’s mode-of-action to accurately match its therapies with patients who will benefit independent of underlying genetic tumor alterations.

Acrivon’s pipeline includes the advanced Phase 2 lead program, ACR-368 (prexasertib), a clinically active CHK1/2 inhibitor, as well as preclinical programs targeting critical nodes in DNA Damage Response (DDR) and cell cycle regulation.

 Acrivon is headquartered in Watertown, MA, and also has operations in Sweden. The role will report to the CFO.

Position Summary

The financial/accounting leader is a hands-on, strategic team player who will provide exceptional leadership support to Acrivon Therapeutics. He/she will play an integral role in developing and implementing appropriate finance/accounting strategies, policies, procedures, tools, systems, and controls. This leadership role will ensure reporting is compliant with GAAP, and oversee the accounting function to ensure accurate and timely financial closes, consolidations, audits and filings.

Principal Responsibilities

Key responsibilities of this role include, but are not limited to:

• Lead the preparation and implementation of the financial strategic plan

• Partner with the business leaders to understand the critical elements and the impact of financial decisions, and provide valuable finance/accounting guidance that helps the business leaders run a profitable business

• Assist in the creation, structuring and implementation of transactions with specific focus on accounting issues. Interpret results and make recommendations

• Develop and maintain annual budgets and provided FP&A support when needed

• Responsible for the timely filing of all required SEC filings

• Provide accurate and timely preparation and dissemination of comprehensive comparative (versus budget) internal monthly financial management reports

• Interface with external auditors and prepare required reports and supporting schedules required for quarterly reviews and annual audit(s). Address any technical accounting issues

• Lead monthly close process by preparing or reviewing reconciliations

• Continuously monitor, maintain and update as necessary systems and internal controls which verify the integrity of all systems, processes and data

• Ensure Sarbanes Oxley/COSO Internal Control Compliance

• Establish and maintain relationships with key vendors and business partners

Qualifications

• BS in accounting, finance, or related. MBA a plus. CPA a plus.
• 7-10+ years of progressive finance and/or accounting and management experience required

• Prior financial/accounting leadership in a start-up life sciences company very desirable

• Prior financial/accounting leadership experience with an IPO very desirable

• Prior financial/accounting clinical, R&D, or commercial accounting experience is a plus

• Strong experience in internal/external financial reporting and analysis

• Strong business acumen and demonstrated ability to multi-task

• Ability to deal with both accounting and operational issues daily and should exhibit leadership by taking a “roll up your sleeves” approach

• Is a team player who can lead, mentor, develop the finance/accounting team

• Excellent verbal and written communication skills

• Experience with reporting requirements, required SEC filings (10-Q, 10-K, 8-K), and relevant software packages

• Knowledge of GAAP, FASB and SOX requirements

• Prior public accounting experience a plus